CAS 1473-73-0: 2-Pyrazinecarboxamide, N-(4-morpholinylmethyl)-, hydrochloride (1:1)

Morinamide hydrochloride is a synthetic antitubercular agent, which is derived from chemical synthesis processes. Its mode of action involves disrupting the synthesis of mycolic acids in the cell walls of Mycobacterium tuberculosis, thereby inhibiting bacterial growth and proliferation. The compound serves primarily as an antimicrobial agent targeting tuberculosis infections. In a laboratory setting, Morinamide hydrochloride is utilized in the study of bacterial resistance mechanisms and the development of novel therapeutic agents. Its specific action on mycolic acid synthesis makes it a valuable tool for researchers aiming to elucidate the pathways involved in mycobacterial cell wall construction and to develop more targeted chemotherapeutic interventions. Due to its crucial role, understanding the mechanisms and efficacy of Morinamide hydrochloride can greatly benefit scientific efforts in combating tuberculosis, especially in light of increasing drug resistance.